Institutional Fund
Bellevue Group AG
Zurich, SwitzerlandCIK 16745465 filings on record
Portfolio Value
$4.20B
Q1 2026
Holdings
155
Reported positions
New Buys
19
Opened this quarter
QoQ Change
-20.4%
from $5.28B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Vertex Pharmaceuticals Inc7.2%
- Argenx Se5.4%
- Regeneron Pharmaceuticals5.1%
- Scholar Rock Hldg Corp4.2%
- Gilead Sciences Inc3.9%
- Revolution Medicines Inc3.6%
- Other70.5%
Portfolio Holdings
155 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals Inc | 681.9K | $304.50M | 7.2% | +788 | Added |
| 2 | Argenx Se | 313.0K | $228.57M | 5.4% | −148.9K | Reduced |
| 3 | Regeneron Pharmaceuticals | 278.7K | $215.31M | 5.1% | +264.7K | Added |
| 4 | Scholar Rock Hldg Corp | 3.58M | $176.22M | 4.2% | −472.0K | Reduced |
| 5 | Gilead Sciences Inc | 1.17M | $163.05M | 3.9% | +1.12M | Added |
| 6 | Revolution Medicines Inc | 1.54M | $150.20M | 3.6% | −3.46M | Reduced |
| 7 | Ionis Pharmaceuticals Inc | 1.82M | $136.56M | 3.2% | −2.98M | Reduced |
| 8 | Intuitive Surgical Inc | 286.7K | $132.14M | 3.1% | −35.4K | Reduced |
| 9 | Viridian Therapeutics Inc | 6.73M | $131.56M | 3.1% | +2.37M | Added |
| 10 | Krystal Biotech Inc | 481.8K | $124.45M | 3.0% | +71.5K | Added |
145 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio